Related Experiment Video
Updated: Aug 11, 2026

Phage-Mediated Genetic Manipulation of the Lyme Disease Spirochete Borrelia burgdorferi
Published on: September 28, 2022
New temperate DNA phage BcP15 acts as a drug resistance vector
D K Hens1, N C Chatterjee, R Kumar
1Sonamukhi College, Sonamukhi, Bankura, India.
Abstract:
This study was designed to determine the role of a new temperate DNA phage BcP15 in relation to drug resistance. The multidrug resistant Shigella flexneri NK1925 was isolated from a patient of Infectious Diseases Hospital, Kolkata, India. This strain contained five plasmids ranging in size from 3 to 212 kb. After curing of five plasmids, this strain became sensitive to antibiotics. A plasmidless multidrug-resistant strain Burkholderia cepacia DR11 was isolated during the survey of microorganisms from coastal waters of deltaic Sunderbans. This strain always released a temperate phage BcP15 into culture supernatant. Turbid plaque formation was observed on the lawn of a plasmidless version (Pl(-)35) of Shigella flexneri NK1925. A few distinct clones (Pl(-)35R) appeared within the region of each plaque after 18 h incubation. S. flexneri NK1925, Pl(-)35, and Pl(-)35R clones showed the same PFGE band pattern of XbaI-digested chromosomal DNA. However, Pl(-)35R clones were resistant to co-trimoxazole, trimethoprim, and eryth- romycin, to which B. cepacia DR11 was also resistant. Southern hybridization results indicated that these three antibiotic resistances in Pl(-)35R clones were due to a BcP15 phage lysogen in the Pl(-)35 version of S. flexneri NK1925.
Insights
A temperate DNA phage, BcP15, was found to transfer drug resistance to Shigella flexneri. This phage lysogenization in S. flexneri conferred multidrug resistance, highlighting phage roles in antibiotic resistance dissemination.
Area of Science:
- Microbiology
- Genetics
- Molecular Biology
Background:
- Multidrug resistance in bacteria is a growing global health concern.
- Bacterial plasmids are known vectors for antibiotic resistance genes.
- The role of bacteriophages in horizontal gene transfer, including antibiotic resistance, is an area of active research.
Purpose of the Study:
- To investigate the role of a novel temperate DNA phage, BcP15, in the context of bacterial drug resistance.
- To determine if phage BcP15 can transfer antibiotic resistance traits between bacterial strains.
Main Methods:
- Isolation and characterization of multidrug-resistant Shigella flexneri and Burkholderia cepacia strains.
- Plasmid curing experiments to assess the role of plasmids in antibiotic resistance.
- Phage plaque assays and lysogenization experiments using Shigella flexneri.
- Pulsed-field gel electrophoresis (PFGE) to analyze chromosomal DNA patterns.
- Southern hybridization to confirm the integration of phage DNA and identify resistance genes.
Main Results:
- Shigella flexneri NK1925 lost antibiotic resistance upon plasmid curing.
- The temperate phage BcP15, released by Burkholderia cepacia DR11, formed plaques on a plasmidless Shigella flexneri NK1925 strain.
- Lysogenization of Shigella flexneri with BcP15 (resulting in Pl(-)35R clones) conferred resistance to co-trimoxazole, trimethoprim, and erythromycin.
- Southern hybridization confirmed that antibiotic resistance in Pl(-)35R clones was due to BcP15 phage lysogenization.
Conclusions:
- The temperate DNA phage BcP15 plays a significant role in the dissemination of antibiotic resistance.
- Phage lysogenization can be a mechanism for acquiring multidrug resistance in bacteria like Shigella flexneri.
- This study underscores the importance of bacteriophages as vectors for antibiotic resistance genes in clinical settings.
Related Concept Videos
DNA Bacteriophages
Transduction
Antibiotic Selection
Plasmids
Bacteriophages of the Human Virome
Genomic DNA in Prokaryotes
Genomic Diversity in Bacteria
Although bacterial genomes are much...

